Status: Recruiting
Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium
This study will assess the use of autologous bone marrow stem cells mobilization using 1,1'-\[1,4-phenylenebis-(methylene)\]-bis-1,4,8,11-tetraazacyclotetradecane (PLERIXAFOR) as an effective medical therapy for the treatment of Asherman's Syndrome (AS), Atrophic Endometrium (AE) and Recurrent Implantation Failure (RIF).
Participants needed: 90
Trial details
Phase: Early Phase 1Age: 18-40Biological sex: FemaleType: InterventionalSponsor: Hugh TaylorUpdated: Nov 12, 2025Locations: 1
Eligibility criteria
Healthy, non pregnant females [+5]
Presence of hydrosalpinx (diagnosed by radiographic or ultrasound imaging) [+7]